Rating Card

premium

Unlock Expert's Rating and Top Picks Portfolio

Curated by Michael O'Reilly since 2020
1550+ opinions with 4.81 rating (one of the best performing expert)

Latest Top Picks

Stock Opinions by The Panic-Proof Portfolio (Stockchase Research)

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate HRTG as a TOP PICK.  Since emerging from last year's California fires, this insurance company has weathered the loss remarkably well.  Latest earnings showed EPS doubled over the year.  It trades at 10x earnings, 2.3x book and supports a ROE of 27%.  We recommend scaling up the stop (from $14.00) to $15.50, looking to achieve $29.00 -- upside potential of 16%.  Yield 0%

(Analysts’ price target is $29.00)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

Following recently reported earnings, we reiterate NCSM as a TOP PICK.  Key metrics including margins and revenues exceeded the upper ranges of management guidance.  Cash reserves are growing for the frac company and should continue as commodity prices stabilize.  Management reported very good progress on business expansion into the Middle East and North Sea regions.  We continue to recommend a stop at $25, looking to achieve $40 -- upside potential of 24%.  Yield 0%

(Analysts’ price target is $40.00)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

Following recently reported earnings, we reiterate RPRX as a TOP PICK.  Their drug portfolio royalty receipts are showing steady growth - up another 12% this year.  Management sees good progress on new projects, including a recent announcement of a partnership with Biogen.  It trades at 17x earnings, 2.1x book, and supports a 12% ROE.  We continue to recommend a stop at $29, looking to achieve $40 -- upside potential of 21%.  Yield 2.5%

(Analysts’ price target is $39.80)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Nov 12/24, Up 17.8%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with PET is progressing well.  To remain disciplined, we recommend trailing up the stop (from $23) to $26 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 06/25, Up 17.1%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with UPWK is progressing well.  To remain disciplined, we recommend trailing up the stop (from $11) to $13 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Apr 24/25, Up 17.6%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with ARDT is progressing well.  To remain disciplined, we recommend trailing up the stop (from $8) to $11 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 20/25, Up 11.5%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with RMD is progressing well.  To remain disciplined, we recommend trailing up the stop (from $209) to $230 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

The shipping sector has come under increasing pressure as the speculation of US tariffs continues.  Earnings estimates for ASC have been heavily discounted into the share price, so if there is any upside impacting the shipping sector the stock should respond very positively.  It trades at 8x earnings, under book value and supports a ROE of 21%.  We continue to recommend a stop at $8.50, looking to achieve $12.50 -- upside potential of 25%.  Yield 4.6%

(Analysts’ price target is $12.50)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

Housing starts have slowed in the US due to tariff uncertainty; however, with trade talks with Canada getting underway in a positive way the fear of rising home building costs may be subsiding.  It trades at 7x earnings, at book value and supports a 16% ROE.  We recommend trailing up the stop (from $47) to $52, looking to achieve $73 -- upside potential of 25%.  Yield 0%

(Analysts’ price target is $73.38)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate PYPL, a leader in online payment systems, as a TOP PICK.  The company is introducing AI into its platform for payments that could well be a game changer and renew their position as the market leader.  It trades at 15x earnings (half its historical valuation), 3.2x book and supports a ROE of 22%.  Cash reserves are once again growing while shares are aggressively bought back.  We continue to recommend a stop at $57, looking to achieve $81 -- upside potential of 18%.  Yield 0%

(Analysts’ price target is $80.94)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Dec 26/24, Up 0%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with DVN has triggered its stop at $31.  To remain disciplined, we recommend covering the position at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Dec 21/23, Down 8.5%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with BNTX has triggered its stop at $95.  To remain disciplined, we recommend covering the position at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 20/25, Down 7.5%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with CPAY is stagnating.  To remain disciplined, we recommend trailing up the stop (from $240) to $270 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

KNT has been producing gold in Papua New Guinea since 2018 and recently reported a 71% increase in Q1 production, just as gold hits all-time high prices.  Cash flow is so strong, they are able to build reserves while aggressively deploying capital on project expansions.  It trades at 20x earnings and supports a ROE of 26%.  We recommend setting a stop-loss at $9.50, looking to achieve $16.00 -- upside potential of 30%.  Yield 0% 

(Analysts’ price target is $16.11)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

HUT operates energy infrastructure platforms for the development of data centres and bitcoin mining in North America.  It recently announced it has created "American Bitcoin" in conjunction with Eric Trump.  It trades at 4x earnings, 1.3x book and supports a 45% ROE.  We recommend setting a stop-loss at $10, looking to achieve $24 -- upside potential of 28%.  Yield 0%

(Analysts’ price target is $41.67)
Showing 1 to 15 of 3,097 entries